Lamivudine/tenofovir

Lamivudine/tenofovir disoproxil, sold under the brand name Cimduo among others, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS in adults and children weighing more than 35 kg. It contains lamivudine and tenofovir disoproxil. It is taken by mouth.

Lamivudine/tenofovir was approved for medical use in the United States in February 2018.